2013
DOI: 10.1093/schbul/sbt064
|View full text |Cite
|
Sign up to set email alerts
|

Dopaminergic Modulation of Probabilistic Reasoning and Overconfidence in Errors: A Double-Blind Study

Abstract: This is the first study to investigate the direct effects of dopaminergic drugs on reasoning biases. The JTC bias and overconfidence in errors showed a differential pattern of dopaminergic modulation, suggesting that they represent different facets of reasoning abnormalities that interact with each other to produce delusions in susceptible individuals.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

7
66
2
1

Year Published

2015
2015
2023
2023

Publication Types

Select...
5
2

Relationship

3
4

Authors

Journals

citations
Cited by 68 publications
(76 citation statements)
references
References 62 publications
7
66
2
1
Order By: Relevance
“…Participants were healthy individuals aged 18-40 years recruited through postings on university recruitment sites. The sample size was calculated based on effect sizes of a previous study by our group 28 on dopaminergic modulation of reasoning biases, with which there was no participant overlap. Exclusion criteria were any past or current psychiatric or neurologic disorder, including substance use disorders; history of schizophrenia or bipolar disorder in a first-degree relative; history of craniocerebral trauma, arterial hypertension, cardiologic or serious medical conditions; pregnancy; or treatment with any psychotropic or other drugs.…”
Section: Participants and Designmentioning
confidence: 99%
See 3 more Smart Citations
“…Participants were healthy individuals aged 18-40 years recruited through postings on university recruitment sites. The sample size was calculated based on effect sizes of a previous study by our group 28 on dopaminergic modulation of reasoning biases, with which there was no participant overlap. Exclusion criteria were any past or current psychiatric or neurologic disorder, including substance use disorders; history of schizophrenia or bipolar disorder in a first-degree relative; history of craniocerebral trauma, arterial hypertension, cardiologic or serious medical conditions; pregnancy; or treatment with any psychotropic or other drugs.…”
Section: Participants and Designmentioning
confidence: 99%
“…28,32 In 3 successive visits, participants were administered either 100 mg of L-dopa and 25 mg of benserazide, 2 mg of haloperidol, or placebo in randomized order and under double-blind conditions (see Andreou and colleagues 28 for dose selection rationale). The 3 visits were separated by at least 7 days to allow a complete wash-out of the drug with the long er half-time (haloperidol).…”
Section: Participants and Designmentioning
confidence: 99%
See 2 more Smart Citations
“…L-DOPA seems to improve encoding but showed no effect on long-term memory and selective attention [65][66][67][68][69][70][71].…”
Section: Catecholamine-o-methyl Transferase Inhibitor: Tolcaponementioning
confidence: 97%